GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 421 filers reported holding GUARDANT HEALTH INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,722,605 | -19.5% | 834,096 | -2.7% | 0.99% | -14.4% |
| Q2 2023 | $30,700,934 | +111.1% | 857,568 | +38.2% | 1.16% | +54.5% |
| Q1 2023 | $14,544,380 | -13.6% | 620,494 | +0.3% | 0.75% | -20.7% |
| Q4 2022 | $16,830,571 | -18.0% | 618,771 | +62.3% | 0.94% | -24.4% |
| Q3 2022 | $20,517,000 | +143.2% | 381,144 | +82.3% | 1.25% | +92.3% |
| Q2 2022 | $8,435,000 | -37.9% | 209,094 | +1.9% | 0.65% | -22.8% |
| Q1 2022 | $13,593,000 | -32.8% | 205,200 | +1.4% | 0.84% | -28.4% |
| Q4 2021 | $20,239,000 | -16.9% | 202,353 | +3.8% | 1.18% | -27.1% |
| Q3 2021 | $24,368,000 | +1.8% | 194,930 | +1.2% | 1.61% | +2.1% |
| Q2 2021 | $23,932,000 | -17.9% | 192,707 | +1.0% | 1.58% | -25.9% |
| Q1 2021 | $29,136,000 | +20.6% | 190,868 | +1.8% | 2.13% | +14.3% |
| Q4 2020 | $24,153,000 | +17.0% | 187,406 | +1.5% | 1.86% | +2.5% |
| Q3 2020 | $20,641,000 | +38.9% | 184,657 | +0.9% | 1.82% | +27.4% |
| Q2 2020 | $14,855,000 | +45.0% | 183,097 | +24.4% | 1.43% | -8.8% |
| Q1 2020 | $10,248,000 | -8.4% | 147,242 | +2.8% | 1.56% | +9.5% |
| Q4 2019 | $11,188,000 | +307.4% | 143,184 | +232.9% | 1.43% | +80.7% |
| Q3 2019 | $2,746,000 | -24.3% | 43,017 | +2.4% | 0.79% | -25.0% |
| Q2 2019 | $3,627,000 | +17.8% | 42,006 | +4.6% | 1.05% | +12.6% |
| Q1 2019 | $3,080,000 | – | 40,155 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |